A GLP-1 receptor agonist liraglutide inhibits endothelial cell dysfunction and vascular adhesion molecule expression in an ApoE-/- mouse model
This article examines the evidence and practical guidance for patients with Hashimoto's thyroiditis considering or currently taking GLP-1 receptor agonists
Iran War Seattle Shooting World Politics Entertainment HealthWatch MoneyWatch Crime Space Sports Brand Studio The Free Press Local News Atlanta Baltimore Bay Area Boston Chicago Colorado Detroit Los Angeles Miami Minnesota New York Philadelphia Pittsburgh Sacramento Texas Live CBS News 24/7 Baltimore Bay Area Boston Chicago Colorado Detroit Los Angeles Miami Minnesota New York Philadelphia Pittsburgh Sacramento Texas 48 Hours 60 Minutes Shows 48 Hours 60 Minutes CBS Evening News CBS Mornings CBS Morning News CBS Reports CBS Saturday Morning The Daily Report The Dish Face the Nation Sunday Morning The Takeout Things That Matter The Uplift CBS News Investigates CBS News Confirmed Podcasts Newsletters Download Our App CBS News Team Executive Team Brand Studio Paramount+ Join Our Talent Community RSS Feeds Boston | News Weather Sports Video WBZ Features All News Health I-Team Politics Education Business Consumer Entertainment NEXT Weather Forecast Radar & Maps School Closings School Visits Earth Matters Share Photos and Videos Join Weather Watchers All Sports CBS Sports HQ Patriots Red Sox Celtics Bruins Revolution Odds New England Living Question Everything It Happens Here Keller @ Large Wednesday's Child Climate Watch Change Makers Contact Us TV Schedule Meet Our Team Station Info Contests Jobs & Internships Download Our App Obituaries Watch CBS News Drug maker Eli Lilly says GLP-1 pill shows large success in clinical trial Eli Lilly, which makes Zepbound and Mounjaro, reports that in a phase one clinical trial, a once daily GLP-1 pill helped lower the hemoglobin A1C, a measure of blood sugar control, in people with type 2 diabetes
This disconnect between high patient satisfaction on Trustpilot and poor BBB standing is not uncommon in telehealth but warrants attention
Wegovy Pill is taken once daily, while the injection is administered once weekly
It could be that, when the drug causes a quick drop in blood sugar, the resulting chemistry change causes blood vessels to the optic nerve to be cut off
